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Abstract
Aims To report a Bangladeshi family
displaying intrafamilial phenotypic
heterogeneity of lattice corneal dystrophy type
I (LCDI) and to identify the causative
mutation.
Methods Molecular genetic analysis was
performed on DNA extracted from all
members of the family. Exons of BIGH3 gene
were amplified by polymerase chain reaction.
Gene mutation and polymorphisms were
identified by heteroduplex and sequence
analyses. Segregation of the mutation in the
family was confirmed by restriction digestion
of amplified gene fragments.
Results A heterozygous C-T transition at
the first nucleotide position of codon 124 of the
BIGH3 gene was detected in the three affected
members and not in the unaffected members
of the family.
Conclusions This is the first report of BIGH3
gene mutation in a Bangladeshi family with
phenotypic heterogeneity. This study confirms
that BIGH3 gene screening should be
undertaken for proper classification of corneal
dystrophy, especially in the absence of
histopathological examination.
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Introduction
Corneal dystrophies are a genetically and
clinically heterogeneous group of disorders that
occurs most frequently bilaterally and are
manifested around the time of puberty,
progressing slowly throughout life.1 Most
corneal dystrophies are inherited as an
autosomal dominant trait.2
Several phenotypic variants of corneal
dystrophies with an autosomal dominant
inheritance were reported to result from specific
mutation(s) in BIGH3 (or transforming growth
factor, b-induced [TGFBI]) gene on chromosome
5q31 (Table 1). Lattice corneal dystrophy type I
(LCDI, OMIM 122200),3–6 LCD type IIIA
(LCDIIIA),7–11 intermediate type
I/IIIA (LCDI/IIIA),9–12 deep stromal LCD
(LCDIV),13–15 granular corneal dystrophy (GCD,
OMIM 121900),3,4,15 Avellino corneal dystrophy
(ACD, OMIM 121900),3,4,16 Thiel Behnke corneal
dystrophy or corneal dystrophy of Bowman
layer type 2 (CDB2, OMIM 602082)3,4,17,20, and
Reis-Bu¨cklers’ corneal dystrophy (RBCD,
OMIM 121900) all result from mutations in
BIGH3.17–20 These conditions are defined by
their clinical manifestations and the histological
characteristics of corneal deposits.21
LCDI (OMIM 122200) has an autosomal
dominant mode of inheritance with variable
expressivity. The disease presents towards the
end of the first or second decade of life and
slowly progresses to cause discomfort and
visual impairment, usually before the sixth
decade. It is characterised by thin greyish, linear
branching deposits of amyloid material that
progressively accumulate in the subepithelial
and stromal layers of the cornea.22 The specific
cause of the amyloid deposits is unclear,
however, they may be secondary to collagen
degeneration or produced by abnormal
keratocytes.
Histopathologically, the white dots and lattice
lines consist of amyloid in the corneal stroma,
which is confirmed histochemically by the pink
to orange staining of the deposits by Congo
red.2
It has been reported that both R124C
and L518P mutations were responsible for
LCDI in both Caucasian and Japanese
families.3–6
In this study, a Bangladeshi family has been
studied both clinically and genetically. Our
Received: 18 April 2003
Accepted in revised form:
18 August 2003
Published online: 12 March
2004
Department of Molecular
Genetics
Institute of Ophthalmology
London, UK
Correspondence:
M F El-Ashry
Department of Molecular
Genetics
Institute of Ophthalmology
11-43, Bath Street, London
ECIV 9EL, UK
Tel:þ44 020 7608 6891
Fax:þ 44 020 7608 6863
E-mail: m_el_ashry@
hotmail.com
Eye (2004) 18, 723–728
& 2004 Nature Publishing Group All rights reserved 0950-222X/04 $30.00
www.nature.com/eye
L
A
B
O
R
A
T
O
R
Y
S
T
U
D
Y
results revealed a heterozygous C to T transition at the
first nucleotide position of codon 124 in the BIGH3 gene
in all affected members. Clinically, the phenotype of
LCDI in the proband and his brother was not typical.
However, the finding of only single mutation in the three
affected members of the family, including the mother
with her typical LCDI phenotype, further indicates that
screening of BIGH3 gene is a mandatory step to arrive at
an unambiguous diagnosis of corneal dystrophy.
Materials and methods
Report of cases
The cases were examined by MFE and LAF.
 Case II-2 (the proband): A 10-year-old boy who was
referred to Moorfields Eye Hospital complaining
of intermittent ocular irritation and mild visual
impairment. The episodes of ocular irritation began
at the age of 5 years. The patient’s best corrected visual
acuity was 6/18 in both eyes. His intraocular
pressure (IOP) was 12 mmHg in the right eye and
11 mmHg in the left eye. He had no history of
keratoplasty.
Slit-lamp biomicroscopic examination revealed
bilateral confluent dense geographic subepithelial
corneal opacities resembling that of RBCD, but
with intervening very fine lattice lines (Figure 1a).
 Case II-3 (the proband’s brother): An 8-year-old boy
affected by the same phenotypic presentation as the
proband and having no history of eye surgery
(Figure 1b).
 Case I-1 (the proband’s mother): A 42-year-old female
had also been examined. She had a past history
of photophobia, lacrimation, and chronic ocular
irritation since childhood. Her visual acuity was 6/24
in both eyes and her IOP was 14 mmHg in the
right eye and 12 mmHg in the left eye. She had no
history of keratoplasty. Slit-lamp examination showed
dense subepithelial opacities with fine lattice lines
in the superficial and midstromal layers of both
corneas (Figure 1c). A full medical history was
obtained and no systemic manifestations of
amyloidosis such as cranial and peripheral
neuropathies, skin changes such as lichen amyloidosis,
cutis laxa, blepharochalasis, protruding lips, and
mask facies were detected.
 Case I-2 (the proband’s father): Unaffected as
determined by the slit-lamp biomicroscopic
examination.
 Case II-1 (the proband’s brother): Unaffected as
determined by the slit-lamp biomicroscopy.
Methods
The study had the approval of Moorfields Eye hospital
Ethics Committee and conformed to the tenets of the
Declaration of Helsinki. An informed consent from all
participants was obtained and blood samples were
collected from the parents, the two affected, and the one
unaffected offspring.
Genomic DNA was extracted from peripheral
leucocytes by standard methods and was amplified using
the polymerase chain reaction (PCR). The intronic
primers used are those listed in (Table 2) spanning exon/
intron boundaries. Amplification was performed in a
DNA thermal cycler using the following conditions:
3 min at 941C followed by 35 cycles of 941C for 1 min,
60–641C for 1 min, and 721C for 1 min, with a final
extension step at 721C for 5 min.
DNA from the participants was amplified using the
intronic primers (4–16) of the BIGH3 gene and analysed
on a heteroduplex gel. The amplified DNA for the exons
that showed positive results with heteroduplex analysis
was purified using a Qiaquick PCR purification kit
(Qiagen) and sequenced using an automatic fluorescent
DNA sequencer (ABI Prism 373A, Perkin Elmer, Foster
City, CA, USA) following the manufacturer’s
instructions. Nucleotide sequences for the coding regions
were compared with the nucleotide sequence of the
published BIGH3 human cDNA.23 Following
identification of the C-T mutation by sequencing, a
cosegregation study was performed using AvaII
restriction enzyme (Promega). The recognition site for
AvaII is 50yG!G(A/T)CCy30 and the C-T change
abolishes the recognition site for the mutated allele. The
Table 1 Reported BIGH3 mutations in different phenotypes of
corneal dystrophy
Phenotypes Mutations References
LCD type I R124C 3–5
L518P 6
LCD type IIIA P501T 7,8
N622H 9
A546T 10
V626S 11
LCD type I/IIIA H626R 9,12
NVP629-630ins 12
H626P 11
G623D 11
T538R 11
LCD type IV L527R 13,14
V124S 15
GCD R555W 3,4
R124S 15
ACD R134H 3,4,16
CDB2 R555Q 3,4,17,20
RBCD R124L 17,18,20
DF540 19,18
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novel sequence alteration found in intron 7 was tested in
100 control chromosomes using DdeI restriction enzyme
(Promega) with recognition sequence 50yC!TNAGy30.
The T-C change abolishes the recognition site of the
enzyme.
Results
Mutation screening of BIGH3 gene by heteroduplex
analysis revealed positive results for exons 4, 7, 11, and
12 in all affected members with the exception of exon 7,
which was positive for the mother only. No changes were
detected in other exons. Direct sequencing analysis of the
proband (II-2) and his mother (I-1) for exon 4 revealed a
heterozygous base pair transition at nucleotide position
417 (C-T), which converts an arginine at codon 124 into
cysteine as shown in Figure 2. This mutation has
previously been reported in LCDI.3–6 The unaffected
members of the family did not have the mutation as
determined by a cosegregation study of the restriction
digest analysis in which the mutation abolishes the
recognition site of AvaII. The three affected members
showed one undigested product of the expected size
(310 bp) for the mutant allele plus two restriction digest
products (190 bp and 110 bp) from the normal allele.
Unaffected members depicted two restriction digest
fragments (190 bp and 110 bp) as shown in Figure 3.
Sequence analysis of the same exon revealed a
polymorphism in intron 4 (IVS4-16C-T) that was
previously reported.4,12
Sequence analysis of the other three PCR products
that were aberrantly migrating as identified by
heteroduplex analysis showed polymorphisms that
did not change the amino-acid sequence of the protein.
The polymorphisms were identified in intron 7
(IVS7þ 46T-C), exon 11 at nucleotide 1416 with C-T
change and in exon 12 at nucleotide 1620 with T-C
change.
Two of these polymorphisms have previously been
identified,4,12 however, the polymorphism in intron 7 is
Figure 1 Slit lamp biomicroscopic findings: (a) the right eye of the proband (II-2) showing geographic subepithelial deposits (atypical
LCDI), (b) the right eye of the proband’s brother (II-3) showing diffuse superficial corneal haze with superimposed amorphous
deposits (atypical LCDI) (c) the left eye of the proband’s mother (I-1) showing the lattice lines typical of LCDI.
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novel. Although the polymorphism in intron 7 was
detected in the mother affected by the typical
picture of LCDI and was not detected in the proband
and his brother, it did not cosegregate with the disease
and was detected in a control population of the same
ethnic origin at a frequency of 92 out of 100
chromosomes.
Table 2 Primers designed for amplification of BIGH3 gene
Exon No. Length Tm Product size MgCl2 Gc% Sequence
Exon 4 forward 20 63.50 310 bp 1.5 mM 50.00 tccctccttctgtcttctgc
Exon 4 reverse 20 63.90 50.00 agactcccattcatcatgcc
Exon 5 forward 20 65.10 330 bp 1.5 mM 50.00 tgtttcccagagttgcaagg
Exon 5 reverse 21 65.10 47.62 ccacacatcggaacagaaatg
Exon 6 forward 18 64.30 310 bp 1.5 mM 61.11 ggggctttgggactatgc
Exon 6 reverse 21 64.30 57.14 gcagaagagttcctgctaggc
Exon 7 forward 20 64.10 315 bp 2 mM 55.00 accagtgaagctgtgtgtgc
Exon 7 reverse 20 63.40 50.00 tggcaggtggtatgttcatc
Exon 8 forward 20 59.50 313 bp 1.5 mM 60.00 ggaccctgacttgacctgag
Exon 8 reverse 20 58.50 50.00 cacaaaggatggcagaagag
Exon 9 forward 20 61.36 320 bp 1.5 mM 55.00 cctgctgatgtgtgtcatgc
Exon 9 reverse 20 56.69 55.00 gggtgctgtaaatcggagag
Exon 10 forward 26 61.50 310 bp 1.5 mM 34.62 tttatctctcatcactctcttcattg
Exon 10 reverse 26 61.00 34.62 tttttacactaatacaagtcccacag
Exon 11 forward 22 64.30 330 bp 1.5 mM 50.00 ggataatgaccctgctacatgc
Exon 11 reverse 20 62.00 50.00 tccccaaggtagaagaaagc
Exon 12 forward 20 63.50 330 bp 1.5 mM 45.00 tcaatccttgatgtgccaac
Exon 12 reverse 21 62.90 42.80 aaaatacctctcagcgtggtg
Exon 13 forward 20 64.10 290 bp 1.5 mM 55.00 catcctgggggtgagatatg
Exon 13 reverse 18 64.90 66.67 ctctgggccctccttgac
Exon 14 forward 26 61.70 317 bp 2 mM 34.62 tttagaacagtttttcttctctccac
Exon 14 reverse 24 63.00 33.33 tccatctcaaaaacaaagaacaag
Exon 15 forward 20 63.00 250 bp 1.5 mM 60.00 gctggagaggctcctctatg
Exon 15 reverse 21 64.20 52.38 ccctcagtcacggttgttatg
Exon 16 forward 18 66.60 250 bp 1.5 mM 61.11 agcagatggcaggcttgg
Exon 16 reverse 19 65.90 57.89 tgagtaggggtggcaatgg
Figure 2 Direct sequencing of exon 4 of the BIGH3 gene. (a) the
proband (II-2) showing heterozygous single base pair transition
(CGC-TGC, R124C). (b) the unaffected father (I-2) showing the
wild-type allele.
Figure 3 The results of cosegregation study by restriction
analysis. M¼Øx174-HaeIII marker; lane 1: undigested 310 bp
PCR product; lanes 2 and 5: AvaII digested product from
unaffected members (II-1) and (I-2) respectively, showing the
digested wild-type alleles (190 bp and 110 bp); lanes 3, 4, and 6:
AvaII digested product from affected members (I-1), (II-2), (II-3),
respectively, carrying the R124C mutation showing the undi-
gested mutated allele (310 bp); lane 7 contains no sample.
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Discussion
In this study, we report a family from Bangladesh with
two different phenotypes, the two affected offspring have
a phenotype that resemble that of RBCD, whereas the
mother has a typical LCDI phenotype.
All affected members of the family have an R124C
mutation in the BIGH3 gene. The same mutation was
found in Caucasian3 and Japanese patients with LCDI.24
This suggests that this mutation occurs independently in
several ethnic groups.5
Molecular genetic analysis of the BIGH3 gene in the
present family did not reveal the R555Q mutation
previously found in Caucasians with CDB23 or the R124L
mutation found in Japanese individuals with RBCD.17
Also, it did not reveal the L518P previously reported
with LCDI.6 Instead, the same R124C mutation
previously associated with LCDI was found in both the
mother (LCDI) and the two affected offspring (atypical
LCDI).
It has been postulated that RBCD may be a variant of
LCD, with a mild to nonexistent deep stromal
pathology.25 Our findings based on clinical and genetic
studies of the family support this theory. It is possible
that the mother’s phenotype originally resembled that of
her offspring and that the development of lattice lines in
her cornea is secondary to chronic irritation produced by
numerous episodes of superficial erosions.
Another possible explanation for the observed variant
phenotype is the effect of a modifier locus in which other
genes affect the phenotypic expression of the mutated
BIGH3 gene. There are well-documented examples of
intrafamilial variable expressivity for deafness in
humans, which have been attributed to modifier gene.26
The fact that the affected members in this family had
not undergone keratoplasty made the categorisation of
corneal dystrophy difficult. However, the genetic
analysis declared that all affected members in this family
belong to one type of corneal dystrophy.
Thus, we conclude that the possibility of RBCD being a
variant of LCDI is reinforced by the study of this family
and that BIGH3 gene screening should be mandatory for
proper classification of corneal dystrophies, especially in
the absence of histopathological examination. Also, the
detection of R124C mutation in a Bangladeshi family for
the first time adds to the previous reports that BIGH3
mutations occur independently in different ethnic
origins.
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